13 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2014
-
01/2003 |
12 | Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2014
-
10/2002 |
11 | interleukin-24 (ST16)IBA
02/2011
-
02/2002 |
7 | Interleukin-10 (Interleukin 10)IBA
08/2010
-
01/2004 |
6 | Proteins (Proteins, Gene)IBA
10/2013
-
01/2003 |
5 | InterleukinsIBA
11/2011
-
08/2003 |
4 | Messenger RNA (mRNA)IBA
02/2012
-
09/2005 |
4 | Nitric Oxide Synthase (NO Synthase)IBA
03/2010
-
10/2002 |
3 | InterferonsIBA
11/2015
-
07/2008 |
3 | Cadherins (E-Cadherin)IBA
06/2012
-
08/2002 |
3 | CytokinesIBA
08/2010
-
12/2004 |
3 | HormonesIBA
04/2010
-
09/2003 |
3 | Cisplatin (Platino)FDA LinkGeneric
03/2010
-
01/2004 |
3 | DNA (Deoxyribonucleic Acid)IBA
06/2009
-
01/2005 |
3 | interleukin-20 receptorIBA
02/2007
-
12/2004 |
2 | Phosphotransferases (Kinase)IBA
08/2014
-
08/2002 |
2 | 3-nitrotyrosineIBA
08/2014
-
09/2008 |
2 | ParaffinIBA
08/2014
-
01/2004 |
2 | Transcription Factors (Transcription Factor)IBA
06/2012
-
01/2012 |
2 | Biological Markers (Surrogate Marker)IBA
04/2007
-
12/2006 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2006
-
10/2002 |
2 | beta CateninIBA
05/2005
-
08/2003 |
2 | RNA (Ribonucleic Acid)IBA
01/2005
-
08/2004 |
1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2014 |
1 | Formaldehyde (Formol)FDA Link
08/2014 |
1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2014 |
1 | GTP Phosphohydrolases (GTPases)IBA
02/2014 |
1 | Small Interfering RNA (siRNA)IBA
02/2014 |
1 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2014 |
1 | Oxidants (Oxidizing Agents)IBA
10/2013 |
1 | LipidsIBA
10/2013 |
1 | Reactive Nitrogen SpeciesIBA
10/2013 |
1 | AntioxidantsIBA
10/2013 |
1 | DNA AdductsIBA
10/2013 |
1 | Type 1 Melanocortin ReceptorIBA
05/2013 |
1 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oateIBA
01/2013 |
1 | Interleukin-2 (IL2)IBA
02/2012 |
1 | PlatinumIBA
01/2012 |
1 | CholesterolIBA
01/2012 |
1 | 1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
01/2012 |
1 | Neutralizing AntibodiesIBA
11/2011 |
1 | Interleukin-1 (Interleukin 1)IBA
11/2011 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2011 |
1 | Caspase 9IBA
02/2011 |
1 | Epidermal Growth Factor Receptor (EGF Receptor)IBA
02/2011 |
1 | Caspase 3 (Caspase-3)IBA
02/2011 |
1 | erlotinib (CP 358,774)FDA Link
02/2011 |
1 | Plant Preparations (Preparation, Plant)IBA
01/2011 |
1 | lycopeneIBA
01/2011 |
1 | ZyflamendIBA
01/2011 |
1 | resveratrolIBA
01/2011 |
1 | isothiocyanic acidIBA
01/2011 |
1 | Transforming Growth Factor beta (TGF-beta)IBA
08/2010 |
1 | Transforming Growth Factor alpha (TGF-alpha)IBA
08/2010 |
1 | Leptin ReceptorsIBA
04/2010 |
1 | LeptinIBA
04/2010 |
1 | Complement System Proteins (Complement)IBA
03/2009 |
1 | Protein Isoforms (Isoforms)IBA
03/2009 |
1 | NF-kappa B (NF-kB)IBA
01/2009 |
1 | Protein Kinases (Protein Kinase)IBA
01/2009 |
1 | U 0126 (UO 126)IBA
01/2009 |
1 | Carbon MonoxideIBA
01/2009 |
1 | Caspase 8 (Caspase-8)IBA
12/2008 |
1 | Dacarbazine (DIC)FDA LinkGeneric
12/2008 |
1 | Caspase 10IBA
12/2008 |
1 | temozolomide (Temodar)FDA LinkGeneric
12/2008 |
1 | WP1066IBA
09/2008 |
1 | 2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA
09/2008 |
1 | 3-morpholino-sydnonimine (SIN 1)IBA
09/2008 |
1 | 4,5-diaminofluorescein diacetateIBA
09/2008 |
1 | ArginaseIBA
09/2008 |
1 | imatinib (Gleevec)FDA Link
08/2008 |
1 | WP760IBA
10/2007 |
1 | ThymineIBA
04/2007 |
1 | GuanineIBA
04/2007 |
1 | CytosineIBA
04/2007 |
1 | AdenineFDA LinkGeneric
04/2007 |
1 | Interleukin-10 ReceptorsIBA
02/2007 |